top of page

[KoreaTechDesk] DNA Corporation recognized as ‘CES 2023 Innovation Awards Honoree’ for its ADHD

Updated: Jan 27, 2023



DNA Corporation recognized as ‘CES 2023 Innovation Awards Honoree’ for its ADHD genetic testing kit



DNA Corporation has been named a CES® 2023 Innovation Awards Honoree for ADHD BANK (ADHD genetic testing kit). This year’s CES Innovation Awards program received a record high number of over 2100 submissions. The announcement of Innovation award honorees was made ahead of CES 2023, the world’s most influential technology event, happening Jan. 5-8 in Las Vegas, NV.

The CES 2023 Innovation Awards honorees, including product descriptions and photos, can be found at CES.tech/innovation. DNA Corporation will showcase its winning products in the Innovation Awards Showcase at CES 2023. DNA Corporation will also exhibit at Eureka Park with Seoul Metropolitan Government group at Ventian Expo Hall D booth #62032.

The CES Innovation Awards program, owned and produced by the Consumer Technology Association (CTA)®, is an annual competition honoring outstanding design and engineering in 28 consumer technology product categories. An elite panel of industry expert judges, including members of the media, designers, engineers and more, reviewed submissions based on innovation, engineering and functionality, aesthetic and design.


DNA Corporation’s ADHD BANK (ADHD genetic testing kit) is an AI-powered DNA data solution to assist physicians diagnose and predict ADHD (Attention-deficit/hyperactivity disorder). Although ADHD is a multifactorial disease, Nature published in 2018 that ADHD has high heritability 74%. Strong genetic feature of ADHD intrigued and motivated DNA Corporation to search for genes associated with ADHD. DNA Corporation now has patented machine with learning algorithms that analyzes the latest genetic biomarkers associated with ADHD.

ADHD BANK is designed to provide more accessible prediction of ADHD to the general public by offering ADHD genetic analysis using the innovative genome technology. Currently, ADHD is clinically diagnosed by physicians using DSM-5 criteria and ADHD questionnaires. Due to a significant shortage of physicians, especially psychiatrist, not only in the United States but all over the world, receiving prompt ADHD diagnosis and proper treatment has been a challenge.

This innovative technology combined with clinical methods are said to tremendously help physicians diagnose challenging cases of ADHD, especially for young children, persons with disability or mental health diseases. In addition, ADHD BANK’s personalized ADHD genetic analysis could assist medical professionals to provide more individually targeted behavioral therapy and medical treatments. DNA Corporation is thrilled to release ADHD BANK that could enable more reliable, affordable, and accessible ADHD genetic analysis across the world.






DNA Corporation founder and CEO Mr. Kyunghwan “David” Koh shared his remarks receiving the award “I feel honored and privileged to be recognized as CES 2023 innovation award honoree. Our three years of dedicated research with determination towards brightening the future of children resulted in our product ADHD BANK. I want to specially thank our DNA Corporation team members and all those who helped us to create and release our product ADHD BANK. I truly hope that ADHD BANK will bring happiness to more children in the world.”


DNA Corporation was founded with a goal of utilizing AI-powered DNA data informatics to enhance the life of children and brighten their future. Company’s current focus is releasing ADHD BANK (ADHD genetic testing kit) that will assist in early detection and provide enhanced and personalized ADHD genetic analysis. The company’s future vision is to expand the service and provide targeted behavioral and intellectual support in addition to ADHD genetic analysis.

DNA Corporation is striving to be a leader in shifting the paradigm from traditional diagnostic medicine to futuristic preventative medicine. The founder and CEO Kyunghwan “David” Koh strongly believes that “children are not things to be molded, but are people to be unfolded” as author Jess Lair stated. By offering variety of personalized genetic analysis in the future, the company hopes to brighten the future of our children and bring happiness to more children in the world.


13 views0 comments

Comentários


bottom of page